MedPath

Intervention of Exercise and Atorvastatin Drug On Heart Natriuretic peptides.

Not Applicable
Conditions
CHD.
Chronic ischaemic heart disease
Registration Number
IRCT2017060633030N2
Lead Sponsor
Medical Science of Shiraz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria; Cardiovascular Patients With At least 30% Stenosis And a History Of Hospital Admission Have to be Considered Criteria Were Selected.

Exclusion Criteria; Not respecting the Recommendations of the Study, the Researchers, Causing Serious Illness or lack of Desire to Continue Research Will be Considered.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brain Natriuretic Peptides. Timepoint: Pre Intervention and 12 Weeks Post Intervention. Method of measurement: Pg/ML With ELISA Method.;Atrum Natriuretic Peptides. Timepoint: Pre Intervention and 12 Weeks Post Intervention. Method of measurement: Pg/ML With ELISA Method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath